drugset / Trial / NCT02183038
Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to assess the efficacy and tolerability of Meloxicam once daily dose of 7.5 mg and 15 mg compared with 1100 mg of naproxen sodium in the symptomatic treatment of acute non bacterial pharyngitis or pharyngo-tonsillitis, over a period of 5 days.
Timeline
- Start
- 1998-07
- Primary completion
- 1999-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meloxicam | Small molecule | 7.5 mg | — |
| Subject | Meloxicam | Small molecule | 15 mg | — |
| Comparator | Naproxen | Small molecule | 1100 mg | — |